Sign in
CompletedPhase 4

Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome

Key facts

Who runs it
National Institute of Kidney Disease and Urology (NIKDU)
Where
Bangladesh1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
100 people enrolled
Started
27 Jan 2024
Ended
31 Oct 2025
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Atorvastatin
Record updated
27 March 2026

Who can take part

Age
8 years to 18 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (9)Hide the full registry criteria

Who can take part

  • Children aged 8-18 years with known cases of steroid sensitive nephrotic syndrome
  • LDL ≥ 130 mg/dl in two consecutive serum fasting lipid profile, at least 4 weeks apart
  • while on remission
  • free of acute infection

Who cannot take part

  • Children with previously diagnosed hyperlipidemia other than Nephrotic Syndrome
  • Children already on lipid lowering drugs
  • Children with steroid resistant nephrotic syndrome
  • Secondary nephrotic syndrome
  • Those parents/patients who refused to participate; Secondary nephrotic syndrome (SLE, amyloidosis etc.) 5. Nephrotic syndrome (initial episode). 6. Children taking Anti TB drug or anticonvulsant drugs. 7. Children having any active liver disease

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To evaluate the effectiveness and safety of Atorvastatin therapy in children with dyslipidemia in steroid sensitive nephrotic syndrome.

The 2 groups in the trial

  • Control arm/Placebo armNo study treatment, for comparison

    Dietary Advice

  • Intervention arm/ AtorvastatinTreatment being tested

    Dietary advice plus atorvastatin

    Treatment: Atorvastatin

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
27 March 2026